Market Cap 12.87M
Revenue (ttm) 6.59M
Net Income (ttm) -10.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -162.82%
Debt to Equity Ratio 0.00
Volume 201,000
Avg Vol 1,245,774
Day's Range N/A - N/A
Shares Out 12.94M
Stochastic %K 61%
Beta 1.47
Analysts Strong Sell
Price Target $8.17

Company Profile

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND...

Industry: Biotechnology
Sector: Healthcare
Phone: 713 400 6400
Address:
2450 Holcombe Blvd, MS: BCM251, Houston, United States
DMoney92
DMoney92 Oct. 24 at 12:36 AM
$MRKR 660,000 shares bought by insiders at $3.20 a share. $1 is a steal. They are anticipating at least $6 a share probably closer to $10. Any day now she erupts. I’ll be grabbing more along the way
2 · Reply
CantNameThatTune
CantNameThatTune Oct. 23 at 10:29 PM
Littles are popping. That time of year $WGRX $VIVK $ASTX $IMG. But they continue to ignore the best one of all $MRKR sitting on a cure for Non-Hodgkin's lymphoma and nobody cares. You will care when it's $10.
2 · Reply
TitusPullo1964
TitusPullo1964 Oct. 23 at 6:02 PM
$MRKR Good results, good news. Price? Far too low! Analysts' estimates are significantly higher. A game of patience.
0 · Reply
SimSimBola
SimSimBola Oct. 23 at 1:37 PM
0 · Reply
GoIrish1776
GoIrish1776 Oct. 23 at 12:40 PM
$MRKR https://theconversation.com/covid-19-mrna-vaccines-could-unlock-the-next-revolution-in-cancer-treatment-new-research-258992
0 · Reply
TitusPullo1964
TitusPullo1964 Oct. 23 at 5:36 AM
$MRKR Current price $1.03 The price has held up well in the red market over the past few days, which I consider very positive.
0 · Reply
birddogsfly
birddogsfly Oct. 22 at 5:34 PM
0 · Reply
johnny6nine
johnny6nine Oct. 22 at 12:43 PM
$ALLR $MRKR $GLMD painful.
0 · Reply
CantNameThatTune
CantNameThatTune Oct. 22 at 11:33 AM
$MRKR A little pro active thinking amongst the frenzy on $BYND and $DNUT in MemeCrazy world, you should look at the plain fact they were both heavily shorted, naked shorted to their 52 week lows if not all time lows. Given this trend to "suddenly" find stocks running, squeezing off those lows and given the recent news, huge trial news the beginning of Nov, and the price targets being well over 1000% above the current price, this is an ideal candidate to just suddenly make it's "Marker" on the field of play.
0 · Reply
GoIrish1776
GoIrish1776 Oct. 22 at 11:10 AM
$MRKR https://www.forbes.com/sites/greglicholai/2025/10/19/blood-test-detects-dozens-of-cancers-early/
1 · Reply
Latest News on MRKR
Marker Therapeutics Announces $16.1 Million Private Placement

Dec 19, 2024, 8:06 AM EST - 11 months ago

Marker Therapeutics Announces $16.1 Million Private Placement


Why Are Marker Therapeutics Shares Trading Lower On Thursday?

Feb 17, 2022, 1:08 PM EST - 4 years ago

Why Are Marker Therapeutics Shares Trading Lower On Thursday?


DMoney92
DMoney92 Oct. 24 at 12:36 AM
$MRKR 660,000 shares bought by insiders at $3.20 a share. $1 is a steal. They are anticipating at least $6 a share probably closer to $10. Any day now she erupts. I’ll be grabbing more along the way
2 · Reply
CantNameThatTune
CantNameThatTune Oct. 23 at 10:29 PM
Littles are popping. That time of year $WGRX $VIVK $ASTX $IMG. But they continue to ignore the best one of all $MRKR sitting on a cure for Non-Hodgkin's lymphoma and nobody cares. You will care when it's $10.
2 · Reply
TitusPullo1964
TitusPullo1964 Oct. 23 at 6:02 PM
$MRKR Good results, good news. Price? Far too low! Analysts' estimates are significantly higher. A game of patience.
0 · Reply
SimSimBola
SimSimBola Oct. 23 at 1:37 PM
0 · Reply
GoIrish1776
GoIrish1776 Oct. 23 at 12:40 PM
$MRKR https://theconversation.com/covid-19-mrna-vaccines-could-unlock-the-next-revolution-in-cancer-treatment-new-research-258992
0 · Reply
TitusPullo1964
TitusPullo1964 Oct. 23 at 5:36 AM
$MRKR Current price $1.03 The price has held up well in the red market over the past few days, which I consider very positive.
0 · Reply
birddogsfly
birddogsfly Oct. 22 at 5:34 PM
0 · Reply
johnny6nine
johnny6nine Oct. 22 at 12:43 PM
$ALLR $MRKR $GLMD painful.
0 · Reply
CantNameThatTune
CantNameThatTune Oct. 22 at 11:33 AM
$MRKR A little pro active thinking amongst the frenzy on $BYND and $DNUT in MemeCrazy world, you should look at the plain fact they were both heavily shorted, naked shorted to their 52 week lows if not all time lows. Given this trend to "suddenly" find stocks running, squeezing off those lows and given the recent news, huge trial news the beginning of Nov, and the price targets being well over 1000% above the current price, this is an ideal candidate to just suddenly make it's "Marker" on the field of play.
0 · Reply
GoIrish1776
GoIrish1776 Oct. 22 at 11:10 AM
$MRKR https://www.forbes.com/sites/greglicholai/2025/10/19/blood-test-detects-dozens-of-cancers-early/
1 · Reply
Viperwilder
Viperwilder Oct. 21 at 2:39 PM
$BYND People buying this, then there's stocks like $MRKR that is a relevant stock and still on 1 USD
0 · Reply
TitusPullo1964
TitusPullo1964 Oct. 21 at 7:48 AM
0 · Reply
Viperwilder
Viperwilder Oct. 20 at 4:47 PM
0 · Reply
Gastone78
Gastone78 Oct. 20 at 4:30 PM
$MRKR $RANI still sure ?
1 · Reply
CantNameThatTune
CantNameThatTune Oct. 19 at 10:33 AM
$RANI I did clearly read the PR. But one thing you'll quickly realized. ANY...I repeat ANY reference to pre-funded warrants is the death knell for any biotech. Trust me, this is NOT my first rodeo with this nonsense. RANI is struggling severely. They already know Rani Pill will never be aapproved in the US. They need cash. So, they ink this deal with Samsara to get cash in the worst deal imaginable. But, just like other biotechs, they cleverly disguise it as a "collaboration" to get a massive number of sheep to chase the stock higher. Roche owns 62% of Chugai but purposely did NOT write the licensing deal. Important to note Roche ranks #5 by cap in biotech. Chugai is the largest biotech in Japan but ranks #283 by size worldwide. Case in point. $MRKR reported a substantial Private Placement on the heels of stellar news with their Apollo study that clearly proves they have a drug that reduces, if not eliminates, Non Hodgkins Lymphoma. That PP was in 12/24 at $3.20. It's now $1.X or so.
1 · Reply
Thewho12
Thewho12 Oct. 18 at 10:43 AM
0 · Reply
TitusPullo1964
TitusPullo1964 Oct. 17 at 12:21 PM
$MRKR Quite a few values ​​in the red today
0 · Reply
Viperwilder
Viperwilder Oct. 16 at 5:34 PM
0 · Reply
WhereAmIGoing
WhereAmIGoing Oct. 16 at 2:05 PM
0 · Reply
TitusPullo1964
TitusPullo1964 Oct. 16 at 1:22 PM
0 · Reply
kellymone2
kellymone2 Oct. 16 at 11:45 AM
$MRKR What's your average? Mine is 1,17$
0 · Reply
Awesom69Trade
Awesom69Trade Oct. 16 at 2:54 AM
$MRKR Take me to $50 is all I ask!!
0 · Reply